Our researchers have collaborative projects with several biomedical and pharmaceutical companies, supported by PhD scholarships from NSW Health. If you are interested in working with us, please get in touch to find out more.
Learn more about the NSW Health PhD Partnership Program.
The ARC CFBD is a multidisciplinary collaboration of researchers from Monash University, the Drug Discovery Initiative, and Griffith University. The Centre provide state-of-the-art training for HDR students, with transformative research programs to build partnerships between university-based researchers and industry-based research end-users.
Learn more aboiut the ARC Centre for Fragment-based Design.
The DDI is proud to host the 2020 SPARK Sydney program in collaboration with the Faculty of Medicine and Health. SPARK is a translational research and education program that provides training, mentorship, and milestone funding to research teams working in early stage drug development. Find out more about the program or apply to participate in SPARK 2020 here.
Learn more about SPARK.
In partnership with MTPConnect, the DDI recently hosted the first Pre-IP forum, where an expert panel of industry representatives and venture capitalists gave feedback and guidance on DDI Members’ Pre-IP research projects across our five disease focus areas.
We are always looking to engage with anyone interested in early stage drug development. We run events throughout the year for researchers, medical professionals, industry representatives and the general public.
Find out more about past and upcoming events here.